Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
6,870.00    115.00 (1.70%)
Bid:
6,855.00
Ask:
6,860.00
Spread: 5.00 (0.073%)
Market Cap: £30.42b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Transaction in Own Shares

3 Mar 2025 07:00

RNS Number : 9826Y
Coca-Cola Europacific Partners plc
03 March 2025
 

Coca-Cola Europacific Partners plc (the "Company")Transactions in Own Shares

 

The Company confirms that on 28 February 2025 it purchased a total of: (i) 38,088 ordinary shares of EUR 0.01 ("ordinary shares") on the US Trading Venues[1] and (ii) 12,756 ordinary shares on the London Trading Venues[2]; in both cases, from Goldman Sachs & Co. LLC, Goldman Sachs International or one of their affiliates, as detailed below.

The repurchased ordinary shares will be cancelled.

 

US Trading Venues

London Stock Exchange

CBOE Europe Limited

(CXE)

 

CBOE Europe Limited

(BXE)

Aquis

Date of purchase

 

28 February 2025

 

28 February 2025

 

28 February 2025

 

28 February 2025

 

28 February 2025

Aggregate number of ordinary shares purchased

38,088

7,654

1,275

3,827

0

Highest price paid (per ordinary share)

USD 87.1400

GBP 69.0000

GBP 68.8000

GBP 69.0000

GBP 0

Lowest price paid (per ordinary share)

USD 85.7200

GBP 68.2000

GBP 68.4000

GBP 68.2000

GBP 0

Volume weighted average price paid (per ordinary share)

USD 86.1433

GBP 68.4792

GBP 68.5738

GBP 68.5719

GBP 0

 

The purchases form part of the Company's share buyback programme announced on 14 February 2025 (the "Programme"). In connection with the Programme, the Company expects to repurchase up to EUR 1 billion of ordinary shares (in aggregate).

This announcement does not constitute, or form part of, an offer or solicitation of an offer for securities in any jurisdiction.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), full details of the transactions, are set out in the Schedule to this announcement available through the link below:

http://www.rns-pdf.londonstockexchange.com/rns/9826Y_1-2025-3-2.pdf

 

CONTACTS

Company Secretariat

Clare Wardle

clare.wardle@ccep.com

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ (and a constituent of the Nasdaq 100), London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP.

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

 

 

 

 

 


[1] The "US Trading Venues" comprise Nasdaq and other applicable US trading venues.

[2] The "London Trading Venues" comprise the London Stock Exchange, CBOE Europe Limited (BXE), CBOE Europe Limited (CXE) and Aquis. Goldman Sachs acquired CREST Depositary Interests on the London Trading Venues, which will be cancelled together with the underlying shares they represent.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUUVARVNUORAR
Date   Source Headline
17th Mar 20225:30 pmRNSDirector/PDMR Shareholding
15th Mar 20226:11 pmRNSAnnual Financial Report
14th Mar 20226:30 pmRNSDirector/PDMR Shareholding
10th Mar 20226:00 pmRNSDirector/PDMR Shareholding
9th Mar 20229:06 amRNSDirector/PDMR Shareholding
8th Mar 20224:00 pmRNSDirector/PDMR Shareholding
4th Mar 20224:00 pmRNSDirector/PDMR Shareholding
1st Mar 20222:00 pmRNSTotal Voting Rights
28th Feb 20225:30 pmRNSDirector/PDMR Shareholding
23rd Feb 20225:30 pmRNSDirector/PDMR Shareholding
16th Feb 20224:35 pmRNSPrice Monitoring Extension
16th Feb 20227:00 amRNSPreliminary Unaudited Results Q4 & FY 2021
1st Feb 20221:30 pmRNSTotal Voting Rights
24th Jan 20223:00 pmRNSDirector/PDMR Shareholding
4th Jan 202212:45 pmRNSTotal Voting Rights
21st Dec 20213:45 pmRNSDirector/PDMR Shareholding
16th Dec 20211:45 pmRNSDirector/PDMR Shareholding
1st Dec 20212:45 pmRNSTotal Voting Rights
23rd Nov 20213:15 pmRNSDirector/PDMR Shareholding
17th Nov 20214:35 pmRNSPrice Monitoring Extension
9th Nov 20217:00 amRNSQ3 Trading Update & FY21 Dividend Declaration
1st Nov 20212:30 pmRNSTotal Voting Rights
25th Oct 20214:41 pmRNSSecond Price Monitoring Extn
25th Oct 20214:36 pmRNSPrice Monitoring Extension
21st Oct 20214:41 pmRNSSecond Price Monitoring Extn
21st Oct 20214:36 pmRNSPrice Monitoring Extension
20th Oct 20214:40 pmRNSSecond Price Monitoring Extn
20th Oct 20214:35 pmRNSPrice Monitoring Extension
20th Oct 20214:30 pmRNSDirector/PDMR Shareholding
15th Oct 20214:41 pmRNSSecond Price Monitoring Extn
15th Oct 20214:36 pmRNSPrice Monitoring Extension
14th Oct 20214:41 pmRNSSecond Price Monitoring Extn
14th Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20212:00 pmRNSTotal Voting Rights
30th Sep 20212:00 pmRNSDirector/PDMR Shareholding
17th Sep 202112:30 pmRNSBlock listing Interim Review
9th Sep 20215:00 pmRNSDirector/PDMR Shareholding
7th Sep 20211:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSResults for the six months ended 2 July 2021
1st Sep 20211:00 pmRNSTotal Voting Rights
20th Aug 20219:30 amRNSDirector/PDMR Shareholding
2nd Aug 20211:30 pmRNSTotal Voting Rights
28th Jul 20214:35 pmRNSPrice Monitoring Extension
20th Jul 202111:30 amRNSDirector/PDMR Shareholding
2nd Jul 20212:00 pmRNSDirector/PDMR Shareholding
1st Jul 20214:30 pmRNSTotal Voting Rights
23rd Jun 20213:00 pmRNSDirector/PDMR Shareholding
11th Jun 20214:35 pmRNSPrice Monitoring Extension
9th Jun 20211:00 pmRNSDirector/PDMR Shareholding
1st Jun 20213:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.